Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT.

Bu L, Li R, Liu H, Feng W, Xiong X, Zhao H, Vollrath D, Shen B, Cheng Z.

Radiology. 2014 Jul;272(1):174-83. doi: 10.1148/radiol.14132042. Epub 2014 Apr 20.

2.
3.

Biodistribution, Radiation Dosimetry, and Clinical Application of a Melanin Targeted PET Probe 18F-P3BZA in Patients.

Ma X, Shengjun W, Wang S, Liu D, Zhao X, Chen H, Kang F, Yang W, Wang J, Cheng Z.

J Nucl Med. 2018 May 31. pii: jnumed.118.209643. doi: 10.2967/jnumed.118.209643. [Epub ahead of print]

PMID:
29853651
4.

In vivo imaging of cell proliferation enables the detection of the extent of experimental rheumatoid arthritis by 3'-deoxy-3'-18f-fluorothymidine and small-animal PET.

Fuchs K, Kohlhofer U, Quintanilla-Martinez L, Lamparter D, Kötter I, Reischl G, Röcken M, Pichler BJ, Kneilling M.

J Nucl Med. 2013 Jan;54(1):151-8. doi: 10.2967/jnumed.112.106740. Epub 2012 Dec 4.

5.

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1098-104. doi: 10.1016/j.ijrobp.2008.12.039. Epub 2009 Apr 20.

PMID:
19386444
6.

Semi-automatic synthesis and biodistribution of N-(2-18F-fluoropropionyl)-bis(zinc (II)-dipicolylamine) (18F-FP-DPAZn2) for AD model imaging.

Wen F, Nie D, Hu K, Tang G, Yao S, Tang C.

BMC Med Imaging. 2017 Apr 21;17(1):27. doi: 10.1186/s12880-017-0200-1.

7.

PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.

Beer AJ, Pelisek J, Heider P, Saraste A, Reeps C, Metz S, Seidl S, Kessler H, Wester HJ, Eckstein HH, Schwaiger M.

JACC Cardiovasc Imaging. 2014 Feb;7(2):178-87. doi: 10.1016/j.jcmg.2013.12.003. Epub 2014 Jan 8.

8.
9.

Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII.

Nielsen CH, Erlandsson M, Jeppesen TE, Jensen MM, Kristensen LK, Madsen J, Petersen LC, Kjaer A.

J Nucl Med. 2016 Jan;57(1):89-95. doi: 10.2967/jnumed.115.154849. Epub 2015 Sep 17.

10.

Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.

Heskamp S, Laverman P, Rosik D, Boschetti F, van der Graaf WT, Oyen WJ, van Laarhoven HW, Tolmachev V, Boerman OC.

J Nucl Med. 2012 Jan;53(1):146-53. doi: 10.2967/jnumed.111.093047. Epub 2011 Dec 15.

11.
12.

Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.

Mou T, Zhao Z, Fang W, Peng C, Guo F, Liu B, Ma Y, Zhang X.

J Nucl Med. 2012 Mar;53(3):472-9. doi: 10.2967/jnumed.111.088096. Epub 2012 Feb 2.

13.

In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.

Khayum MA, Doorduin J, Antunes IF, Kwizera C, Zijlma R, den Boer JA, Dierckx RA, de Vries EF.

Nucl Med Biol. 2015 Jun;42(6):561-9. doi: 10.1016/j.nucmedbio.2015.02.003. Epub 2015 Feb 11.

14.

Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part II. In Vivo Imaging of Bone Marrow Stromal Cells in Swine with PET/CT and MR Imaging.

Parashurama N, Ahn BC, Ziv K, Ito K, Paulmurugan R, Willmann JK, Chung J, Ikeno F, Swanson JC, Merk DR, Lyons JK, Yerushalmi D, Teramoto T, Kosuge H, Dao CN, Ray P, Patel M, Chang YF, Mahmoudi M, Cohen JE, Goldstone AB, Habte F, Bhaumik S, Yaghoubi S, Robbins RC, Dash R, Yang PC, Brinton TJ, Yock PG, McConnell MV, Gambhir SS.

Radiology. 2016 Sep;280(3):826-36. doi: 10.1148/radiol.2016151150. Epub 2016 Jun 22.

15.

(18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.

Iagaru A, Mosci C, Shen B, Chin FT, Mittra E, Telli ML, Gambhir SS.

Radiology. 2014 Nov;273(2):549-59. doi: 10.1148/radiol.14140028. Epub 2014 Jul 16.

PMID:
25033190
16.

[¹⁸F]DPA-714 as a biomarker for positron emission tomography imaging of rheumatoid arthritis in an animal model.

Pottier G, Bernards N, Dollé F, Boisgard R.

Arthritis Res Ther. 2014 Mar 13;16(2):R69. doi: 10.1186/ar4508.

17.

Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth.

Flores LG 2nd, Yeh HH, Soghomonyan S, Young D, Bankson J, Hu Q, Alauddin M, Huff V, Gelovani JG.

Mol Imaging Biol. 2013 Apr;15(2):175-85. doi: 10.1007/s11307-012-0588-5.

18.

2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.

Wang JL, Parhi AK, Oya S, Lieberman B, Kung MP, Kung HF.

Nucl Med Biol. 2008 May;35(4):447-58. doi: 10.1016/j.nucmedbio.2008.02.009.

19.

18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain.

Yui J, Maeda J, Kumata K, Kawamura K, Yanamoto K, Hatori A, Yamasaki T, Nengaki N, Higuchi M, Zhang MR.

J Nucl Med. 2010 Aug;51(8):1301-9. doi: 10.2967/jnumed.109.072223. Epub 2010 Jul 21.

20.

Melanin-targeted preclinical PET imaging of melanoma metastasis.

Ren G, Miao Z, Liu H, Jiang L, Limpa-Amara N, Mahmood A, Gambhir SS, Cheng Z.

J Nucl Med. 2009 Oct;50(10):1692-9. doi: 10.2967/jnumed.109.066175. Epub 2009 Sep 16.

Supplemental Content

Support Center